Cargando…
Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design
The quest for an effective HIV-1 vaccine began as soon as the virus causing AIDS was identified. After several disappointing attempts, results of the Phase-III RV144 trial in Thailand were a beacon of hope for the field demonstrating correlation between protection and immunological markers. In order...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594512/ https://www.ncbi.nlm.nih.gov/pubmed/28893288 http://dx.doi.org/10.1186/s12981-017-0164-9 |